Saturday, November 20, 2021

Laurus Labs acquires 26.62% stake in ImmunoACT for Rs 46 crore

Laurus Labs acquires 26.62% stake in ImmunoACT for Rs 46 crore Additionally, Laurus Labs#39; senior management will also invest in ImmunoACT for a 5.64 percent stake for approximately Rs 9.75 crore at the same price and terms, the company said in a BSE filing

from Moneycontrol Business News https://ift.tt/30D6z4C
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bitcoin stays near $64K, Ethereum underperforms as weak risk appetite keeps crypto markets under pressure

Bitcoin traded near $64,000 and Ethereum underperformed as risk appetite weakened. The global crypto market capitalization edged down 2% to ...